Regulatory T cells in cancer immunotherapy

Cited by (1,001)

Items 101–200 of 1,001

1. Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
   Jin U. Kang, Chao Zhang, Wen‐Zhao Zhong · 2021 · 癌症：英文版
2. Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential
   Lingling Wang, Ying Liang, Chunxia Zhao, Peijun Ma, Shulin Zeng, Dongen Ju, Ming Zhao, Ming‐Lung Yu, Yun Shi · 2025 · Signal Transduction and Targeted Therapy
3. Immune escape: A critical hallmark in solid tumors
   Keywan Mortezaee · 2020 · Life Sciences
4. Immune suppression and reversal of the suppressive tumor microenvironment
   Kanako Shimizu, Tomonori Iyoda, Masahiro Okada, Satoru Yamasaki, Shin‐ichiro Fujii · 2018 · International Immunology
5. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
   Salman M. Toor, Khaled Murshed, Mahmood Al‐Dhaheri, Mahwish Khawar, Mohamed Abu Nada, Eyad Elkord · 2019 · Frontiers in Immunology
6. A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
   Toshihiko Doi, Kei Muro, Hiroshi Ishii, Terufumi Kato, Takahiro Tsushima, Mitsuhiro Takenoyama, Satoshi Oizumi, Kazuto Gemmoto, Hideaki Suna, Kouki Enokitani et al. · 2019 · Clinical Cancer Research
7. Regulatory T cells in immune checkpoint blockade antitumor therapy
   An Zhang, Tao Fan, Yixiao Liu, Guanhua Yu, Chunxiang Li, Zheng Jiang · 2024 · Molecular Cancer
8. The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis
   Paul Laissue · 2019 · Molecular Cancer
9. Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone
   Shiyao Zhou, Qi Shang, Ningning Wang, Qian Li, Aixin Song, Yuxia Luan · 2020 · Journal of Controlled Release
10. GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)
    F. Anthony Romero, Jeremy M. Murray, Kwong Wah Lai, Vickie Tsui, Brian K. Albrecht, Le An, Maureen H. Beresini, Gladys de Leon Boenig, Sarah M. Bronner, Emily W. Chan et al. · 2017 · Journal of Medicinal Chemistry
11. Chemokines and cancer: new immune checkpoints for cancer therapy
    N Karin · 2018 · Current Opinion in Immunology
12. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1
    Youqiong Ye, Xinwei Kuang, Zuozhong Xie, Long Liang, Zhao Zhang, Yongchang Zhang, Fangyu Ma, Qian Gao, Ruimin Chang, Heng‐Huan Lee et al. · 2020 · Genome Medicine
13. Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma
    Yuki Kitano, Hirohisa Okabe, Yo‐ichi Yamashita, Shigeki Nakagawa, Yoichi Saito, Naoki Umezaki, Masayo Tsukamoto, Takanobu Yamao, Kensuke Yamamura, Kota Arima et al. · 2017 · British Journal of Cancer
14. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
    Hongying Zhang, Yongliang Liu, Jieya Liu, Jinzhu Chen, Jiao Wang, Hui Ming Hua, Yangfu Jiang · 2024 · Journal of Hematology & Oncology
15. Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
    Nan Zhang, Hao Zhang, Wantao Wu, Ran Zhou, Shuyu Li, Zeyu Wang, Ziyu Dai, Liyang Zhang, Fangkun Liu, Zaoqu Liu et al. · 2022 · Theranostics
16. Single‐Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma
    Zhihua Ou, Shitong Lin, Jiaying Qiu, Wencheng Ding, Peidi Ren, Dongsheng Chen, Jiaxuan Wang, Yihan Tong, Di Wu, Ao Chen et al. · 2022 · Advanced Science
17. Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer
    Daniel O. Villarreal, Andrew L'Huillier, Susan Armington, Cristina Mottershead, Elena V. Filippova, Brandon Coder, Robert G. Petit, Michael F. Princiotta · 2018 · Cancer Research
18. Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer
    Shichao Zhang, Zuquan Hu, Jinhua Long, Guiming Zhu, Yun Wang, Yi Jia, Jing Zhou, Yan Ouyang, Zhu Zeng · 2019 · Journal of Cancer
19. Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
    Phuong H. D. Nguyen, Siming Ma, Cheryl Zi Jin Phua, Neslihan Arife Kaya, Hannah L. H. Lai, Chun Jye Lim, Jia Qi Lim, Martin Wasser, Liyun Lai, Wai Leong Tam et al. · 2021 · Nature Communications
20. Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer
    Zehang Jiang, Zhixian Liu, Mengyuan Li, Cai Chen, Xiaosheng Wang · 2018 · Translational Oncology
21. Cancer metabolism and tumor microenvironment: fostering each other?
    Yiyuan Yuan, Huimin Li, Pu Wang, Leilei Chen, Dong Sheng Guo, Hongfei Jiang, Bo He, Siyuan Qin, Kui Wang, Na Li et al. · 2021 · Science China Life Sciences
22. Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
    Yingqi Qiu, Tong Chen, Rong Hu, Ruiyi Zhu, Chujun Li, Yingchen Ruan, Xiaoling Xie, Yuhua Li · 2021 · Biomarker Research
23. Identification of pyroptosis-related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in colorectal cancer
    Wei Song, Jun Ren, Rensheng Xiang, Can Kong, Tao Fu · 2021 · OncoImmunology
24. Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer
    Zhe Gong, Jieyun Zhang, Weijian Guo · 2020 · Cancer Medicine
25. Immunotherapeutic interventions of Triple Negative Breast Cancer
    Zehuan Li, Yiran Qiu, Weiqi Lu, Ying Jiang, Jin Wang · 2018 · Journal of Translational Medicine
26. The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer
    Nanna Jørgensen, Gry Persson, Thomas Vauvert F. Hviid · 2019 · Frontiers in Immunology
27. Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
    Nicolás Gonzalo Núñez, Fiamma Berner, Ekaterina Friebel, Susanne Unger, Nina Wyss, Julia M. Martínez Gómez, Mette-Triin Purde, Rebekka Niederer, Maximilian Porsch, Christa Lichtensteiger et al. · 2023 · Med
28. Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
    Yun Liu, Jianfeng Guo, Leaf Huang · 2020 · Theranostics
29. Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
    Florent Peyraud, Jean‐Philippe Guégan, D. Bodet, Sophie Cousin, Alban Bessede, Antoîne Italiano · 2022 · Frontiers in Immunology
30. Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance
    Fang Wei, Dan Wang, Junyuan Wei, Niwen Tang, Le Min Tang, Fang Xiong, Can Jie Guo, Ming Zhou, Xiaoling Li, Guiyuan Li et al. · 2020 · Cellular and Molecular Life Sciences
31. Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease
    Weiqi Zhang, Xu Liu, Yicheng Zhu, Xinnan Liu, Yunting Gu, Xueyu Dai, Bin Li · 2021 · European Journal of Immunology
32. Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy
    Hartmann, Felix J., Babdor, Joel, Gherardini, Pier Federico, Amir, El-Ad D., Jones, Kyle, Sahaf, Bita, Marquez, Diana M., Krutzik, Peter, O’Donnell, Erika, Sigal, Natalia et al. · 2019 · Cell Reports
33. Virus‐like particles for vaccination against cancer
    Mona Omar Mohsen, Daniel E. Speiser, Alexander K. Knuth, Martin F. Bachmann · 2019 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
34. Nanoparticles for tumor immunotherapy
    Xinlong Zang, Xiuli Zhao, Haiyang Hu, Mingxi Qiao, Yihui Deng, Dawei Chen · 2017 · European Journal of Pharmaceutics and Biopharmaceutics
35. Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37
    Dhifaf Sarhan, Keli Lee Hippen, Amanda M. Lemire, Skyler Hying, Xianghua Luo, Todd R. Lenvik, Julie Curtsinger, Zachary Davis, Bin Zhang, Sarah Cooley et al. · 2018 · Cancer Immunology Research
36. Blockade of β-Catenin–Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration
    Lu Ji, Wei Qian, Liming Gui, Zhongzhong Ji, Pan Yin, Guan Ning Lin, You Wang, Bin Ma, Wei‐Qiang Gao · 2020 · Cancer Research
37. A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function
    Chin-San Loo, Jovylyn Gatchalian, Yuqiong Liang, Mathias Leblanc, Mingjun Xie, Josephine Ho, Bhargav Venkatraghavan, Diana C. Hargreaves, Ye Zheng · 2020 · Immunity
38. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity
    Yano, Hiroshi, Andrews, Lawrence P., Workman, Creg J., Vignali, Dario A. A. · 2019 · Immunology
39. Acute pharmacological degradation of Helios destabilizes regulatory T cells
    Wang, Eric S., Verano, Alyssa L., Nowak, Radosław P., Yuan, J. Christine, Donovan, Katherine A., Eleuteri, Nicholas A., Yue, Hong, Ngo, Kenneth H., Lizotte, Patrick H., Gokhale, Prafulla C. et al. · 2021 · Nature Chemical Biology
40. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
    Zihai Li, Wenru Song, Mark P. Rubinstein, Delong Liu · 2018 · Journal of Hematology & Oncology
41. Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
    Justine Cinier, Margaux Hubert, Laurie Besson, Anthony Di Roio, Céline Rodriguez, Vincent Lombardi, Christophe Caux, Christine Ménétrier‐Caux · 2021 · Cancers
42. Review of the Immune Checkpoint Inhibitors in the Context of Cancer Treatment
    Norah A. Alturki · 2023 · Journal of Clinical Medicine
43. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis
    Kumar, Prabhakaran, Saini, Shikha, Prabhakar, Bellur S. · 2020 · Seminars in Cancer Biology
44. Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo
    Yu Qing Cao, Yonghui Feng, Liwei Gao, Xiao-Ying Li, Quanxiu Jin, Yuying Wang, Yingying Xu, Feng Jin, Shi‐Long Lu, Minjie Wei · 2019 · International Immunopharmacology
45. Gut microbiota-mediated immunomodulation in tumor
    Liu, Xinyi, Chen, Yanjie, Zhang, Si, Dong, Ling · 2021 · Journal of Experimental & Clinical Cancer Research
46. Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
    Yuefei Zhu, Xiangrong Yu, Soracha Thamphiwatana, Ying Zheng, Zhiqing Pang · 2020 · Acta Pharmaceutica Sinica B
47. Tumor microenvironment and immunotherapy of oral cancer
    Chang Xin Liu, Min Wang, Haiyang Zhang, Chunyan Li, Tianshou Zhang, Hong Shi Liu, Song Zhu, Jie Chen · 2022 · European journal of medical research
48. CD25 : A potential tumor therapeutic target
    Yujia Peng, Yiran Tao, Ya Zhang, Jiaxing Wang, Jinliang Yang, Yuxi Wang · 2022 · International Journal of Cancer
49. Dynamic single-cell phenotyping of immune cells using the microfluidic platform DropMap
    Yacine Bounab, Klaus Eyer, Sophie Dixneuf, Magda Rybczynska, Cécile Chauvel, Maxime Mistretta, Trang Tran, Nathan Aymerich, Guilhem Chenon, Jean‐François Llitjos et al. · 2020 · Nature Protocols
50. Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
    Maureen L. Drakes, Patrick J. Stiff · 2018 · Cancers
51. Directing Traffic: How to Effectively Drive T Cells into Tumors
    Annabelle J. Anandappa, Catherine J. Wu, Patrick Alexander Ott · 2020 · Cancer Discovery
52. Ultrasound in tumor immunotherapy: Current status and future developments
    Yi-Ju Ho, Ju-Pi Li, Ching‐Hsiang Fan, Hao-Li Liu, Chih‐Kuang Yeh · 2020 · Journal of Controlled Release
53. Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
    Zhangfeng Zhong, Chi Teng Vong, Feiyu Chen, Horyue Tan, Cheng Zhang, Ning Wang, Liao Cui, Yitao Wang, Yibin Feng · 2022 · Medicinal Research Reviews
54. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
    Aras Toker, Linh T. Nguyen, Simone C. Stone, S.Y. Cindy Yang, Sarah Rachel Katz, Patricia Ann Shaw, Blaise Alexander Clarke, Danny Ghazarian, Ayman Al‐Habeeb, Alexandra Maria Easson et al. · 2018 · Clinical Cancer Research
55. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
    Yifei Zhu, Xinyan Li, Lei Wang, Xiwei Hong, Jie Yang · 2022 · Frontiers in Endocrinology
56. CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells
    Myung‐Chul Kim, Nicholas C. Borcherding, Kawther Khalid Ahmed, Andrew P. Voigt, Ajaykumar Vishwakarma, Ryan H. Kolb, Paige Kluz, Gaurav Pandey, Umasankar De, Theodore T. Drashansky et al. · 2021 · Nature Communications
57. Lysine lactylation in the regulation of tumor biology
    Zijian Yang, Yingqi Zheng, Qiang Gao · 2024 · Trends in Endocrinology and Metabolism
58. Mechanisms of Immune Tolerance in Leukemia and Lymphoma
    Emily K. Curran, James K. Godfrey, Justin Paul Kline · 2017 · Trends in Immunology
59. Exosomes from heat‐stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL‐6
    Danfeng Guo, Yinghu Chen, Shoujie Wang, Lei Yu, Yingying Shen, Haijun Zhong, Yunshan Yang · 2017 · Immunology
60. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
    Xueting Xia, Zongxin Yang, Qisi Lu, Zhenyun Liu, Lei Wang, Jinwen Du, Yuhua Li, Dong‐Hua Yang, Shaojie Wu · 2024 · Molecular Cancer
61. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy
    Jonathan Forrest Anker, Anum F. Naseem, Hanlin Mok, Anthony J. Schaeffer, Sarki Abba Abdulkadir, Praveen Thumbikat · 2018 · Nature Communications
62. Cancer-associated adipocytes as immunomodulators in cancer
    Wu, Qi, Li, Bei, Li, Juanjuan, Sun, Si, Yuan, Jingping, Sun, Shengrong · 2021 · Biomarker Research
63. Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumor microenvironment for effective chemo-immunotherapy
    Xia Dong, Afeng Yang, Yun Bai, Deling Kong, Feng Lv · 2019 · Biomaterials
64. Cancer vaccines: current status and future directions
    Yi Zhou, Yuquan Wei, Xiaohe Tian, Xiawei Wei · 2025 · Journal of Hematology & Oncology
65. Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment
    Hridesh Banerjee, Hector M Nieves-Rosado, Aditi Kulkarni, Benjamin Murter, Kyle V. McGrath, Uma R. Chandran, Alexander Chang, Andrea L. Szymczak-Workman, Lazar N. Vujanovic, Greg M. Delgoffe et al. · 2021 · Cell Reports
66. A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
    Laurel B. Darragh, Michael W. Knitz, Junxiao Hu, Eric T. Clambey, Jennifer Backus, Andrew Dumit, Von Samedi, Andrew N. Bubak, Casey S. Greene, Timothy V. Waxweiler et al. · 2022 · Nature Cancer
67. Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1+ fibroblast and CCR8+ Treg cell interactions
    Ming Wang, Zhongyu Qin, Yan Yan, Yan Yan, Xixi Duan, Xiaohan Yao, Ziming Jiang, Wenqing Li, Zhihai Qin · 2022 · Cancer Immunology Immunotherapy
68. Novel antitumor therapeutic strategy using CD4+ T cell-derived extracellular vesicles
    Sanghee Shin, Inseong Jung, Dokyung Jung, Christine Seul Ki Kim, Sung‐Min Kang, Suyeon Ryu, Sung-Jin Choi, Soojeong Noh, Jongwon Jeong, Beom Yong Lee et al. · 2022 · Biomaterials
69. An Update on Immunotherapy for Solid Tumors: A Review
    Toan Duc Pham, Sara Roth, Joseph Cherng Huei Kong, Glen Guerra, Vignesh Narasimhan, Lloyd A. Pereira, Jayesh Desai, Alexander Graham Heriot, Robert George Ramsay · 2018 · Annals of Surgical Oncology
70. Therapeutic Potential of Regulatory T Cells in Preeclampsia—Opportunities and Challenges
    Sarah Anne Robertson, Ella S. Green, Alison S. Care, Lachlan M. Moldenhauer, Jelmer Riemer Prins, Mary Louise Hull, Simon Charles Barry, Gustaaf Dekker · 2019 · Frontiers in Immunology
71. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells
    Themis Alissafi, Aikaterini Hatzioannou, A.I. Legaki, Athina Varveri, Panayotis Verginis · 2019 · Journal of Autoimmunity
72. The effects of TNF ‐α/ TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer
    Yang Qu, Xianhao Wang, Shuai Bai, Liling Niu, Gang Zhao, Yuan Yao, Bin Li, Hui Li · 2021 · International Journal of Cancer
73. Medical gas plasma technology: Roadmap on cancer treatment and immunotherapy
    Sander Bekeschus · 2023 · Redox Biology
74. Therapeutic targeting of DNA methylation alterations in cancer
    Abigail V. Lee, Kevin A. Nestler, Katherine Bakshian Chiappinelli · 2024 · Pharmacology & Therapeutics
75. Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
    Tanaka, Atsushi, Nishikawa, Hiroyoshi, Noguchi, Shinsuke, Sugiyama, Daisuke, Morikawa, Hiromasa, Takeuchi, Yoshiko, Ha, Danbee, Shigeta, Naoya, Kitawaki, Toshio, Maeda, Yuka et al. · 2020 · Journal of Experimental Medicine
76. Novel TCR-based biologics: mobilising T cells to warm ‘cold’ tumours
    Kate L. Lowe, David K. Cole, Rupert Kenefeck, Ita OKelly, Marco Lepore, Bent K. Jakobsen · 2019 · Cancer Treatment Reviews
77. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
    Lan Yu, Yi Ding, Ting Wan, Ting Deng, He Huang, Jihong Liu · 2021 · Frontiers in Immunology
78. aPKC‐ι/P‐Sp1/Snail signaling induces epithelial–mesenchymal transition and immunosuppression in cholangiocarcinoma
    Yawei Qian, Wei Yao, Tao Yang, Yan Yang, Yan Liu, Qi Shen, Jian Zhang, Weipeng Qi, Jianming Wang · 2017 · Hepatology
79. Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology
    Ernesto Bockamp, Sebastian Rosigkeit, Dominik Siegl, Detlef Schuppan · 2020 · Cells
80. CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer
    Shingo Maeda, Kohei Murakami, Akiko Inoue, Tomohiro Yonezawa, Naoaki Matsuki · 2019 · Cancer Immunology Research
81. Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes
    Chunbo Li, Keqin Hua · 2022 · Frontiers in Immunology
82. The Crosstalk between Microbiome and Immune Response in Gastric Cancer
    Rihab Nasr, Ali I. Shamseddine, Deborah Mukherji, Farah J. Nassar, Sally Naji Temraz · 2020 · International Journal of Molecular Sciences
83. Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer
    Sandeep Pallerla, Ata ur Rahman Mohammed Abdul, Jill M. Comeau, Seetharama D. S. Jois · 2021 · International Journal of Molecular Sciences
84. Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy
    Tasneem Abaza, Mostafa K. Abd El‐Aziz, Kerolos Ashraf Daniel, Paraskevi Karousi, Maria Papatsirou, Sherif Ashraf Fahmy, Nadia Μ. Hamdy, Christos K. Kontos, Rana Ahmed Youness · 2023 · International Journal of Molecular Sciences
85. TP53 Mutations Promote Immunogenic Activity in Breast Cancer
    Zhixian Liu, Zehang Jiang, Yingsheng Gao, Lirui Wang, Cai Chen, Xiaosheng Wang · 2018 · Journal of Oncology
86. Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells
    Kim, Myeong Joon, Kim, Kyungsoo, Park, Hyo Jin, Kim, Gil-Ran, Hong, Kyeong Hee, Oh, Ji Hoon, Son, Jimin, Park, Dong Jin, Kim, Dahae, Choi, Je-Min et al. · 2023 · Nature Immunology
87. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications
    Yu‐Tzu Tai, Liang Lin, Lijie Xing, Shih‐Feng Cho, Tengteng Yu, Chirag Acharya, Kenneth Wen, Phillip A. Hsieh, John Dulos, Andrea van Elsas et al. · 2018 · Leukemia
88. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model
    Rong Wang, Wenli Feng, Hao Wang, Lina Wang, Xiao Qi Yang, Feifei Yang, Yingchi Zhang, Xiaoli Liu, Dongyue Zhang, Qian Ren et al. · 2019 · Cancer Letters
89. Thymus involution sets the clock of the aging T-cell landscape: Implications for declined immunity and tissue repair
    Yehezqel Elyahu, Alon Monsonego · 2020 · Ageing Research Reviews
90. Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes
    Emiliano Roselli, Rawan G. Faramand, Marco L. Davila · 2021 · Journal of Clinical Investigation
91. Breast Cancer Vaccines: Disappointing or Promising?
    Siyuan Zhu, Ke‐Da Yu · 2022 · Frontiers in Immunology
92. Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations
    Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot, Roberto Bortolotti, Vito Racanelli, Orazio Caffo, Bruno Giometto, Alvise Berti, Antonello Veccia · 2024 · Cancers
93. AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
    Ram Hari Pokhrel, Suman Acharya, Jae-Hee Ahn, Ye Gu, Mahesh Pandit, Jong‐Oh Kim, Yun‐Yong Park, Ben Kang, Hyun‐Jeong Ko, Jae‐Hoon Chang · 2021 · Molecular Cancer
94. The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development
    Arielle Elkrief, Reilly Pidgeon, Saman Maleki Vareki, Meriem Messaoudene, Bastien Castagner, Bertrand Routy · 2025 · Nature Reviews Drug Discovery
95. Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy
    David G. Millar, Rakesh R. Ramjiawan, Kosuke Kawaguchi, Nisha Gupta, Chen Jiang, Songfa Zhang, Takashi Nojiri, William W. Ho, Shuichi Aoki, Keehoon Jung et al. · 2020 · Nature Biotechnology
96. Targeting tumor-associated macrophages in head and neck squamous cell carcinoma
    Bolei Li, Min Ren, Xuedong Zhou, Qi Han, Lei Cheng · 2020 · Oral Oncology
97. Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
    Ana Santiso, Ákos Heinemann, Julia Kargl · 2024 · Pharmacological Reviews
98. Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy
    Munn, David H., Sharma, Madhav D., Johnson, Theodore S. · 2018 · Cancer Research
99. Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80
    Ashkan Shahbandi, Fang-Yen Chiu, Nathan Ungerleider, Raegan M. Kvadas, Zeinab Mheidly, Meijuan J.S. Sun, Di Tian, Daniel A. Waizman, Ashlyn Y. Anderson, Heather L. Machado et al. · 2022 · Nature Cancer
100. Regulators of CD8+ T cell exhaustion
     Qinli Sun, Chen Dong · 2025 · Nature reviews. Immunology